1. Home
  2. FNKO vs TNXP Comparison

FNKO vs TNXP Comparison

Compare FNKO & TNXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FNKO
  • TNXP
  • Stock Information
  • Founded
  • FNKO 2017
  • TNXP 2007
  • Country
  • FNKO United States
  • TNXP United States
  • Employees
  • FNKO N/A
  • TNXP N/A
  • Industry
  • FNKO Recreational Games/Products/Toys
  • TNXP Biotechnology: Pharmaceutical Preparations
  • Sector
  • FNKO Consumer Discretionary
  • TNXP Health Care
  • Exchange
  • FNKO Nasdaq
  • TNXP Nasdaq
  • Market Cap
  • FNKO 225.8M
  • TNXP 207.5M
  • IPO Year
  • FNKO 2017
  • TNXP N/A
  • Fundamental
  • Price
  • FNKO $4.85
  • TNXP $33.33
  • Analyst Decision
  • FNKO Buy
  • TNXP Strong Buy
  • Analyst Count
  • FNKO 4
  • TNXP 2
  • Target Price
  • FNKO $9.88
  • TNXP $585.00
  • AVG Volume (30 Days)
  • FNKO 1.2M
  • TNXP 1.1M
  • Earning Date
  • FNKO 08-07-2025
  • TNXP 08-15-2025
  • Dividend Yield
  • FNKO N/A
  • TNXP N/A
  • EPS Growth
  • FNKO N/A
  • TNXP N/A
  • EPS
  • FNKO N/A
  • TNXP N/A
  • Revenue
  • FNKO $1,024,890,000.00
  • TNXP $10,041,000.00
  • Revenue This Year
  • FNKO N/A
  • TNXP $11.66
  • Revenue Next Year
  • FNKO $9.22
  • TNXP $793.18
  • P/E Ratio
  • FNKO N/A
  • TNXP N/A
  • Revenue Growth
  • FNKO N/A
  • TNXP N/A
  • 52 Week Low
  • FNKO $3.50
  • TNXP $6.76
  • 52 Week High
  • FNKO $14.65
  • TNXP $137.25
  • Technical
  • Relative Strength Index (RSI)
  • FNKO 55.06
  • TNXP 52.50
  • Support Level
  • FNKO $4.72
  • TNXP $33.41
  • Resistance Level
  • FNKO $5.39
  • TNXP $37.42
  • Average True Range (ATR)
  • FNKO 0.32
  • TNXP 3.48
  • MACD
  • FNKO 0.05
  • TNXP -1.12
  • Stochastic Oscillator
  • FNKO 68.35
  • TNXP 33.66

About FNKO Funko Inc.

Funko Inc is an us-based pop culture consumer products company. It creates whimsical, fun, and different products that enable the customer to express their affinity for their favorite through the movie, TV show, video game, musician, or sports team. The company's current products are principally figures, fashion accessories, apparel, plush products, accessories, homewares, and NFTs. The company sells its products through a diverse network of retail customers across multiple retail channels, including specialty retailers, mass-market retailers, and e-commerce sites. The company generates the majority of its revenue from the core collectibles products.

About TNXP Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.

Share on Social Networks: